144 related articles for article (PubMed ID: 7911261)
1. Imaging of bronchial carcinoid tumours with indium-111 pentetreotide.
O'Byrne KJ; O'Hare NJ; Freyne PJ; Luke DA; Clancy LJ; Prichard JS; Carney DN
Thorax; 1994 Mar; 49(3):284-6. PubMed ID: 7911261
[TBL] [Abstract][Full Text] [Related]
2. Uptake of In-111 pentetreotide by pleural plaques.
Lonneux M; Jamar F; Leners N; Pieters T; Pauwels S
Clin Nucl Med; 1998 May; 23(5):298-301. PubMed ID: 9596154
[TBL] [Abstract][Full Text] [Related]
3. Comment on primary localization of an ectopic ACTH-producing bronchial carcinoid tumor by indium111 pentetreotide scintigraphy.
Reincke M; Allolio B; Arlt W; Körber C
J Clin Endocrinol Metab; 1999 Sep; 84(9):3399-400; author reply 3402-3. PubMed ID: 10487718
[No Abstract] [Full Text] [Related]
4. Intraoperative detection of a bronchial carcinoid with a radiolabeled somatostatin analog.
Rodriguez JA; Meyers MO; Jacome TH; Failla P; Harrison LH
Chest; 2002 Mar; 121(3):985-8. PubMed ID: 11888987
[TBL] [Abstract][Full Text] [Related]
5. Differentiation between carcinoid and sarcoid with F-18 FDG PET and In-111 pentetreotide.
Avram AM; Mackie GC; Schneider BJ; Kalemkerian GP; Shulkin BL
Clin Nucl Med; 2006 Apr; 31(4):197-200. PubMed ID: 16550010
[TBL] [Abstract][Full Text] [Related]
6. Hilar bronchial carcinoid tumor: increased peritumoral vascular expression of somatostatin-2 receptor on an octreotide study?
Koh E; Patrikeos A; Steens R; Robins P
Clin Nucl Med; 2001 Oct; 26(10):870-1. PubMed ID: 11564931
[No Abstract] [Full Text] [Related]
7. Acromegaly as manifestation of a bronchial carcinoid tumour.
Filosso PL; Donati G; Rena O; Oliaro A
Asian Cardiovasc Thorac Ann; 2003 Jun; 11(2):189. PubMed ID: 12878580
[No Abstract] [Full Text] [Related]
8. Scintigraphic assessment of pituitary adenomas and several diseases by indium-111-pentetreotide.
Tumiati MN; Facchi E; Gatti C; Bossi A; Longari V
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):98-100. PubMed ID: 9002761
[TBL] [Abstract][Full Text] [Related]
9. [Cushing's syndrome secondary to bronchial carcinoid tumor: use of octreoScan in the location diagnosis].
Gómez Merino E; Navarro Martínez A; Solís del Pozo JE; Andrés Mompeán E; Requejo R
An Med Interna; 2003 Jan; 20(1):52. PubMed ID: 12666316
[No Abstract] [Full Text] [Related]
10. [Detection of somatostatin receptors in tumors in the area of the head and neck and their clinical importance].
Kau RJ; Wagner-Manslau C; Saumweber DM; Arnold W
Laryngorhinootologie; 1994 Jan; 73(1):21-6. PubMed ID: 7908199
[TBL] [Abstract][Full Text] [Related]
11. Localization of adrenocorticotropic hormone-secreting bronchial carcinoid tumor by somatostatin-receptor scintigraphy.
Weiss M; Yellin A; Husza'r M; Eisenstein Z; Bar-Ziv J; Krausz Y
Ann Intern Med; 1994 Aug; 121(3):198-9. PubMed ID: 7912484
[No Abstract] [Full Text] [Related]
12. Follow-up of a carcinoid tumor in the middle ear by in-111 pentetreotide scintigraphy.
Martínez-Lázaro R; Cortes-Blanco A; Moreno-Selva A; Morote MB
Clin Nucl Med; 2007 Jun; 32(6):466-7. PubMed ID: 17515757
[No Abstract] [Full Text] [Related]
13. Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.
Macfarlane D; Gonin J; Wieland D; Mangner T; Froelich J; Beierwaltes W; Shapiro B
Eur J Nucl Med; 1996 Feb; 23(2):131-40. PubMed ID: 8925846
[TBL] [Abstract][Full Text] [Related]
14. Octreotide scanning for carcinoid tumours.
Critchley M
Postgrad Med J; 1997 Jul; 73(861):399-402. PubMed ID: 9338023
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin-receptor scintigraphy of subcutaneous and thyroid metastases from bronchial carcinoid.
Krausz Y; Pfeffer MR; Glaser B; Lafair J
J Nucl Med; 1996 Sep; 37(9):1537-9. PubMed ID: 8790214
[TBL] [Abstract][Full Text] [Related]
16. Single photon emission computerized tomography increases the sensitivity of indium-111-pentetreotide scintigraphy in detecting abdominal carcinoids.
Schillaci O; Scopinaro F; Danieli R; Angeletti S; Tavolaro R; Annibale B; Cannas P; Marignani M; Colella AC; Delle Fave G
Anticancer Res; 1997; 17(3B):1753-6. PubMed ID: 9179229
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeled somatostatin analog scintigraphy in medullary thyroid carcinoma and carcinoid tumor.
Rufini V; Salvatori M; Saletnich I; Valenza V; Maussier ML; Martino G; Corsello SM; Pantusa M; Casolo A; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):140-4. PubMed ID: 9002774
[TBL] [Abstract][Full Text] [Related]
18. Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue.
Dörr U; Räth U; Sautter-Bihl ML; Guzman G; Bach D; Adrian HJ; Bihl H
Eur J Nucl Med; 1993 May; 20(5):431-3. PubMed ID: 8100192
[TBL] [Abstract][Full Text] [Related]
19. The radioguided 111In-pentetreotide surgery in the management of ACTH-secreting bronchial carcinoid.
Porziella V; Cesario A; Lococo F; Cafarotti S; Margaritora S; D'Errico G; Granone P
Eur Rev Med Pharmacol Sci; 2011 Jun; 15(6):587-91. PubMed ID: 21796863
[TBL] [Abstract][Full Text] [Related]
20. SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors.
Schillaci O; Scopinaro F; Angeletti S; Tavolaro R; Danieli R; Annibale B; Gualdi G; Delle Fave G
J Nucl Med; 1996 Sep; 37(9):1452-6. PubMed ID: 8790191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]